{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:54:29Z","timestamp":1785128069466,"version":"3.55.0"},"reference-count":38,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To investigate whether abatacept (ABA) causes more adverse events (AE) than conventional synthetic disease-modifying antirheumatic drugs (csDMARD) after orthopedic surgery in patients with rheumatoid arthritis (RA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A retrospective multicenter nested case\u2013control study was performed in 18 institutions. Patients receiving ABA (ABA group) were matched individually with patients receiving csDMARD and\/or steroids (control group). Postoperative AE included surgical site infection, delayed wound healing, deep vein thrombosis or pulmonary embolism, flare, and death. The incidence rates of the AE in both groups were compared with the Mantel-Haenszel test. Risk factors for AE were analyzed by logistic regression model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>A total of 3358 cases were collected. After inclusion and exclusion, 2651 patients were selected for matching, and 194 patients in 97 pairs were chosen for subsequent comparative analyses between the ABA and control groups. No between-group differences were detected in the incidence rates of each AE or in the incidence rates of total AE (control vs ABA: 15.5% vs 20.7% in total, 5.2% vs 3.1% in death).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Compared with csDMARD and\/or steroids without ABA, adding ABA to the treatment does not appear to increase the incidence rates of postoperative AE in patients with RA undergoing orthopedic surgery. Large cohort studies should be performed to add evidence for the perioperative safety profile of ABA.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.181100","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T16:25:23Z","timestamp":1560615923000},"page":"502-509","source":"Crossref","is-referenced-by-count":14,"title":["Does Abatacept Increase Postoperative Adverse Events in Rheumatoid Arthritis Compared with Conventional Synthetic Disease-modifying Drugs?"],"prefix":"10.3899","volume":"47","author":[{"given":"Hiromu","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyoshi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2363-9803","authenticated-orcid":false,"given":"Takumi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2171-614X","authenticated-orcid":false,"given":"Koji","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"Kanbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Momohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the JOSRA Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,6,15]]},"reference":[{"key":"2021110311500913000_47.4.502.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207838"},{"key":"2021110311500913000_47.4.502.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212131"},{"key":"2021110311500913000_47.4.502.3","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.40090","article-title":"Twenty-year outcome and association between early treatment and mortality and disability in an inception cohort of patients with rheumatoid arthritis: results from the Norfolk Arthritis Register","volume":"69","author":"Gwinnutt","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021110311500913000_47.4.502.4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/art.40091","article-title":"Brief report: rheumatoid arthritis as the underlying cause of death in thirty-one countries, 1987\u20132011: trend analysis of World Health Organization mortality database","volume":"69","author":"Kiadaliri","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021110311500913000_47.4.502.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209562"},{"key":"2021110311500913000_47.4.502.6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jbspin.2016.07.007","article-title":"Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review","volume":"83","author":"Minichiello","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2021110311500913000_47.4.502.7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/s10165-011-0457-0","article-title":"Standard treatment in daily clinical practice for early rheumatoid arthritis improved disease activity from 2001 to 2006","volume":"21","author":"Nakajima","year":"2011","journal-title":"Mod Rheumatol"},{"key":"2021110311500913000_47.4.502.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.107599"},{"key":"2021110311500913000_47.4.502.9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.38384","article-title":"US trends in rates of arthroplasty for inflammatory arthritis including rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritis","volume":"66","author":"Mertelsmann-Voss","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021110311500913000_47.4.502.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu340"},{"key":"2021110311500913000_47.4.502.11","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0713-3"},{"key":"2021110311500913000_47.4.502.12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212424"},{"key":"2021110311500913000_47.4.502.13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/art.38344","article-title":"Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts","volume":"66","author":"Nikiphorou","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021110311500913000_47.4.502.14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150238"},{"key":"2021110311500913000_47.4.502.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208669"},{"key":"2021110311500913000_47.4.502.16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/14397595.2015.1014302","article-title":"Postoperative complications in patients with rheumatoid arthritis using a biological agent - A systematic review and meta-analysis","volume":"25","author":"Ito","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2021110311500913000_47.4.502.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev364"},{"key":"2021110311500913000_47.4.502.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212339"},{"key":"2021110311500913000_47.4.502.19","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-012-0683-0"},{"key":"2021110311500913000_47.4.502.20","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/acr.22056","article-title":"Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry","volume":"65","author":"Godot","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2021110311500913000_47.4.502.21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150240"},{"key":"2021110311500913000_47.4.502.22","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170046"},{"key":"2021110311500913000_47.4.502.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207870"},{"key":"2021110311500913000_47.4.502.24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/art.39399","article-title":"Comparative risk of hospitalized infection associated with biologic agents in rheumatoid arthritis patients enrolled in Medicare","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021110311500913000_47.4.502.25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3109\/14397595.2013.874758","article-title":"Abatacept management during the perioperative period in patients with rheumatoid arthritis: report on eight orthopaedic procedures","volume":"24","author":"Nishida","year":"2014","journal-title":"Mod Rheumatol"},{"key":"2021110311500913000_47.4.502.26","first-page":"629","article-title":"Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry","volume":"56","author":"Latourte","year":"2017","journal-title":"Rheumatology"},{"key":"2021110311500913000_47.4.502.27","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/art.40149","article-title":"2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"69","author":"Goodman","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021110311500913000_47.4.502.28","doi-asserted-by":"publisher","DOI":"10.1186\/ar3087"},{"key":"2021110311500913000_47.4.502.29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.semarthrit.2015.01.008","article-title":"Rheumatoid arthritis: perioperative management of biologics and DMARDs","volume":"44","author":"Goodman","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2021110311500913000_47.4.502.30","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1073133"},{"key":"2021110311500913000_47.4.502.31","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-016-0609-5"},{"key":"2021110311500913000_47.4.502.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-6553(99)70088-X"},{"key":"2021110311500913000_47.4.502.33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.7.689"},{"key":"2021110311500913000_47.4.502.34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep376"},{"key":"2021110311500913000_47.4.502.35","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"2021110311500913000_47.4.502.36","doi-asserted-by":"publisher","DOI":"10.1002\/art.21841"},{"key":"2021110311500913000_47.4.502.37","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22077"},{"key":"2021110311500913000_47.4.502.38","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170366"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.181100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T18:53:15Z","timestamp":1635965595000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.181100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.3899\/jrheum.181100"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.181100","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]}}}